CN102552275B - 头孢哌酮钠和他唑巴坦钠组合物注射用粉针剂 - Google Patents
头孢哌酮钠和他唑巴坦钠组合物注射用粉针剂 Download PDFInfo
- Publication number
- CN102552275B CN102552275B CN 201210014047 CN201210014047A CN102552275B CN 102552275 B CN102552275 B CN 102552275B CN 201210014047 CN201210014047 CN 201210014047 CN 201210014047 A CN201210014047 A CN 201210014047A CN 102552275 B CN102552275 B CN 102552275B
- Authority
- CN
- China
- Prior art keywords
- sodium
- injection
- tazobactam
- cefoperazone
- powder ampoule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210014047 CN102552275B (zh) | 2012-01-17 | 2012-01-17 | 头孢哌酮钠和他唑巴坦钠组合物注射用粉针剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210014047 CN102552275B (zh) | 2012-01-17 | 2012-01-17 | 头孢哌酮钠和他唑巴坦钠组合物注射用粉针剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102552275A CN102552275A (zh) | 2012-07-11 |
CN102552275B true CN102552275B (zh) | 2013-06-26 |
Family
ID=46399734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210014047 Active CN102552275B (zh) | 2012-01-17 | 2012-01-17 | 头孢哌酮钠和他唑巴坦钠组合物注射用粉针剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102552275B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446160A (zh) * | 2013-09-10 | 2013-12-18 | 海南永田药物研究院有限公司 | 一种含注射用头孢哌酮钠和盐酸利多卡因注射液的药物组合物 |
CN104013629B (zh) * | 2014-06-18 | 2015-12-02 | 重庆福安药业集团庆余堂制药有限公司 | 头孢哌酮钠他唑巴坦钠的复方药物组合物及其制备工艺 |
CN104382908A (zh) * | 2014-09-21 | 2015-03-04 | 四川制药制剂有限公司 | 注射用头孢哌酮钠他唑巴坦钠组合物 |
CN104367579A (zh) * | 2014-09-21 | 2015-02-25 | 四川制药制剂有限公司 | 注射用头孢哌酮钠他唑巴坦钠的制备方法 |
CN105748482B (zh) * | 2016-03-18 | 2017-07-18 | 海南通用三洋药业有限公司 | 一种注射用头孢哌酮钠他唑巴坦钠药物组合物的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1857225A (zh) * | 2006-06-09 | 2006-11-08 | 广州贝氏药业有限公司 | 一种含有头孢曲松钠和盐酸利多卡因的注射用无菌分装制剂 |
CN1868478A (zh) * | 2005-05-26 | 2006-11-29 | 广东诺康药业有限公司 | 注射用头孢哌酮钠和他唑巴坦钠复方制剂 |
CN1943578A (zh) * | 2006-06-09 | 2007-04-11 | 广州贝氏药业有限公司 | 一种含有头孢曲松钠和盐酸利多卡因的注射用药物组合物 |
CN101348493A (zh) * | 2008-09-02 | 2009-01-21 | 海南数尔药物研究有限公司 | 高纯度药物及其制备方法 |
-
2012
- 2012-01-17 CN CN 201210014047 patent/CN102552275B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1868478A (zh) * | 2005-05-26 | 2006-11-29 | 广东诺康药业有限公司 | 注射用头孢哌酮钠和他唑巴坦钠复方制剂 |
CN1857225A (zh) * | 2006-06-09 | 2006-11-08 | 广州贝氏药业有限公司 | 一种含有头孢曲松钠和盐酸利多卡因的注射用无菌分装制剂 |
CN1943578A (zh) * | 2006-06-09 | 2007-04-11 | 广州贝氏药业有限公司 | 一种含有头孢曲松钠和盐酸利多卡因的注射用药物组合物 |
CN101348493A (zh) * | 2008-09-02 | 2009-01-21 | 海南数尔药物研究有限公司 | 高纯度药物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102552275A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Barza et al. | Pharmacokinetics of the penicillins in man | |
CN102552275B (zh) | 头孢哌酮钠和他唑巴坦钠组合物注射用粉针剂 | |
Falagas et al. | Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence | |
Zembower et al. | The utility of aminoglycosides in an era of emerging drug resistance | |
Popovic et al. | Fosfomycin: an old, new friend? | |
Lamb et al. | Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections | |
Swabb et al. | Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects | |
Drusano et al. | The acylampicillins: mezlocillin, piperacillin, and azlocillin | |
CA2713989A1 (en) | Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens | |
US20100197650A1 (en) | Compositions and methods of treatment comprising ceftaroline | |
Fortner et al. | Piperacillin sodium: antibacterial spectrum, pharmacokinetics, clinical efficacy, and adverse reactions | |
Dowling | Peptide Antibiotics: Polymyxins, glycopeptides, bacitracin, and fosfomycin | |
Rahman et al. | A novel antibiotic agent, cefiderocol, for multidrug-resistant Gram-negative bacteria | |
Davis et al. | Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and iv administration | |
CN104095809B (zh) | 克林霉素磷酸酯注射液药物组合物和制法 | |
Bourget et al. | How to minimize toxic exposure to pyridine during continuous infusion of ceftazidime in patients with cystic fibrosis? | |
Strausbaugh et al. | Comparative penetration of six antibiotics into the cerebrospinal fluid of rabbits with experimental staphylococcal meningitis | |
CN101574351A (zh) | 一种注射用头孢美唑制剂及其制备方法 | |
Baines et al. | Intravenous administration of sodium colistimethate | |
Saslaw | Cephalosporins | |
Saptarini et al. | Stability studies of Amoxicillin and gentamicin injection in intravenous infusions | |
Zozaya et al. | Pharmacokinetics of a single bolus intravenous, intramuscular and subcutaneous dose of disodium fosfomycin in horses | |
Walters et al. | Therapeutic use of cephazolin to prevent complications of spine surgery | |
Harding et al. | The pharmacokinetic behaviour of ceftazidime in man and the relationship between serum levels and the in vitro susceptibility of clinical isolates | |
Fabre et al. | The behaviour in man of CP 15,464, a carbenicillin absorbed following oral administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHANDONG LUOXIN PHARMACY GROUP CO., LTD. Free format text: FORMER NAME: SHANDONG LUOXIN PHARMACY STOCK CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Seven of 276017 Shandong province Linyi city Luozhuang District Patentee after: Shandong Luo Xin Pharmaceutical Group Plc Address before: Seven of 276017 Shandong province Linyi city Luozhuang District Patentee before: SHANDONG LUOXIN PHARMACY STOCK Co., LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190531 Address after: 276017 Luoqi Road, Luozhuang District, Linyi City, Shandong Province Co-patentee after: Shandong Luoxin Pharmaceutical Group Hengxin Pharmacy Co., Ltd. Patentee after: Shandong Luo Xin Pharmaceutical Group Plc Co-patentee after: Shandong Yu Xin pharmaceutcal corporation, Ltd Address before: 276017 Luoqi Road, Luozhuang District, Linyi City, Shandong Province Patentee before: Shandong Luo Xin Pharmaceutical Group Plc |